Bills › 91st General Assembly
Relating to schedule III controlled substances, and making penalties applicable
Sponsored by Sen. Doug Campbell (R)
Where it is now
- Done: IntroducedFebruary 20, 2025
- Done: SubcommitteeFebruary 25, 2025
- Stopped: Senate committeeDied when the General Assembly ended
- Next: Passes the Senate
- Next: House committeeFunnel: by March 20, 2026
- Next: Passes the House
- Next: To the Governor
- Next: Signed into law
Died when the session ended The 2026 session adjourned on May 3, 2026, the General Assembly’s last regular session. Bills that didn’t pass both chambers died. What’s a funnel?
What’s in it
AI summary This bill adds misoprostol, mifepristone, and methotrexate to the list of Schedule III controlled substances. People who manufacture, distribute, or give out these drugs would be committing a felony. Those convicted could face fines ranging from $1,000 to $50,000.1
Read the official explanation
This bill relates to schedule III controlled substances. The bill includes misoprostol, mifepristone, and methotrexate as schedule III controlled substances. A person who manufactures, distributes, or dispenses a schedule III controlled substance commits a class “C” felony, and in addition to the provisions of Code section 902.9, subsection 1, paragraph “d”, shall be punished by a fine of not less than $1,000 nor more than $50,000.
Why it matters. People who manufacture, distribute, or dispense misoprostol, mifepristone, or methotrexate would face new felony charges and fines between $1,000 and $50,000. These three drugs would be reclassified as schedule III controlled substances.2
Senate subcommittee
Named February 25, 2025. It hasn’t reported yet.
Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part
Similar bills
- SF 2155 Relating to schedule III controlled substances, and making penalties applicable91st General Assembly · In committeeNearly identical
Matched by wording or an identical title.